Anna-Léa Kahn
Impact in
- Health top 5%
- Vaccine Coverage and Hesitancy
- Infectious Diseases top 10%
- Viral gastroenteritis research and epidemiology
- SARS-CoV-2 and COVID-19 Research
Papers in
- Health 16
- Vaccine Coverage and Hesitancy 16
-
- Influenza Virus Research Studies 4
- Virology and Viral Diseases 2
- Hepatitis B Virus Studies 2
- Co-authors
- Roland W. Sutter (7 shared papers)Debra Kristensen (7 shared papers)Birgitte Giersing (7 shared papers)Anthony Burton (2 shared papers)Alina Tejeda (1 shared paper)R. Bruce Aylward (1 shared paper)Manuel Dı́az (1 shared paper)Sonia Resik (1 shared paper)
- Journals
- Vaccine (9 papers)The Journal of Infectious Diseases (4 papers)Vaccines (3 papers)BMC Public Health (1 paper)Vaccine X (1 paper)
- Partner nations
- SwitzerlandUnited StatesPakistan
In The Last Decade
Anna-Léa Kahn
25 papers receiving 484 citations
Peers
Comparison fields: 5 of 72
- Health 146
- Infectious Diseases 171
- Cardiology and Cardiovascular Medicine 175
- Pharmaceutical Science 23
- Epidemiology 109
Countries citing papers authored by Anna-Léa Kahn
This map shows the geographic impact of Anna-Léa Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna-Léa Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna-Léa Kahn more than expected).
Fields of papers citing papers by Anna-Léa Kahn
This network shows the impact of papers produced by Anna-Léa Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna-Léa Kahn. The network helps show where Anna-Léa Kahn may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna-Léa Kahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 106 | |
| 2 | 2016 | 54 | |
| 3 | 2014 | 51 | |
| 4 | 2016 | 43 | |
| 5 | 2012 | 27 | |
| 6 | 2017 | 24 | |
| 7 | 2014 | 23 | |
| 8 | 2021 | 22 | |
| 9 | 2021 | 20 | |
| 10 | 2017 | 19 | |
| 11 | 2021 | 15 | |
| 12 | 2021 | 14 | |
| 13 | 2017 | 13 | |
| 14 | 2011 | 11 | |
| 15 | 2017 | 10 | |
| 16 | 2020 | 10 | |
| 17 | 2022 | 10 | |
| 18 | 1964 | 6 | |
| 19 | 2022 | 6 | |
| 20 | 2024 | 5 |
About Anna-Léa Kahn
Anna-Léa Kahn is a scholar working on Health, Epidemiology, Cardiology and Cardiovascular Medicine, Infectious Diseases and Molecular Biology, having authored 27 papers that have together received 506 indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (16 papers), Viral Infections and Immunology Research (6 papers), Influenza Virus Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Virology and Viral Diseases (2 papers), Hepatitis B Virus Studies (2 papers), Viral gastroenteritis research and epidemiology (2 papers) and Retinal and Optic Conditions (1 paper). The work is most often cited by research in Health (146 citations), Infectious Diseases (171 citations), Cardiology and Cardiovascular Medicine (175 citations), Pharmaceutical Science (23 citations) and Epidemiology (109 citations). Anna-Léa Kahn has collaborated with scholars based in Switzerland, United States and Pakistan. Frequent co-authors include Roland W. Sutter, Debra Kristensen, Birgitte Giersing, Anthony Burton, Alina Tejeda, R. Bruce Aylward, Manuel Dı́az, Sonia Resik, Luís Sarmiento and Magilé Fonseca. Their work appears in journals such as Vaccine, The Journal of Infectious Diseases, Vaccines, BMC Public Health and Vaccine X.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.